Clinical Trial Update: TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tick-borne encephalitis vaccination in allergic patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Diseases
• Tick-borne Encephalitis

Snippet

Sponsor: Medical University of Vienna | Conditions: Vaccine Responsiveness in Allergy, Vaccine Responsiveness During Allergy De-sensitization Treatment | Phase 4 | Status: COMPLETED | Results posted: 2019-10-25